Quaker Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Quaker Wealth Management's BMRN Position: Q3 2026 in Review
Quaker Wealth Management held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2026 at 4 shares worth $240. The position accounts for ﹤0.01% of the portfolio, ranked #840.
Quaker Wealth Management first reported a position in BMRN in Q4 2025 and has held it in 4 quarters since. The position peaked at $452 in Q1 2026. 559 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Quaker Wealth Management held 4 shares of BioMarin Pharmaceuticals worth $240 as of Q3 2026.
- Quaker Wealth Management left its BioMarin Pharmaceuticals share count unchanged in Q3 2026.
- BioMarin Pharmaceuticals made up ﹤0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #840 holding.
- Quaker Wealth Management first reported a position in BioMarin Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- Quaker Wealth Management's BioMarin Pharmaceuticals position peaked at $452 in Q1 2026.
- 559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.